Thomas M. DeMelfi

AMG 706, an Oral, Multikinase Inhibitor that Selectively Targets Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors, Potently Inhibits Angiogenesis and Induces Regression in Tumor Xenografts

Anthony Polverino, Angela Coxon, Charlie Starnes et al. · Cancer Research · 2006 · 283 citations · Full text

Tumor Xenografts, Pharmacotherapy, Tumor Biology +19

Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors

Michele Potashman, James Bready, Angela Coxon et al. · Journal of Medicinal Chemistry · 2007 · 166 citations · Full text

Regulation of Thrombin Receptors on Human Umbilical Vein Endothelial Cells

Marílyn J. Woolkalís, Thomas M. DeMelfi, Nadine Blanchard et al. · Journal of Biological Chemistry · 1995 · 107 citations · Full text

Evaluation of Isolated Cases of Salmonellosis by Plasmid Profile Analysis: Introduction and Transmission of a Bacterial Clone by Precooked Roast Beef

Lee W. Riley, G. T. DiFerdinando, Thomas M. DeMelfi et al. · The Journal of Infectious Diseases · 1983 · 90 citations

Pathogen Detection, Plasmid Profile Analysis, Pathology +17

Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis

Daniel S. La, Julie Belzile, James Bready et al. · Journal of Medicinal Chemistry · 2008 · 73 citations · Full text

Pharmacotherapy, Pharmaceutical Chemistry, Novel 2,3-Dihydro-1,4-benzoxazines +20